{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T10:10:22Z","timestamp":1789726222497,"version":"4.0.1"},"reference-count":9,"publisher":"SAGE Publications","issue":"4","license":[{"start":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T00:00:00Z","timestamp":1753660800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmacy Practice"],"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:p>To describe a case of Fournier\u2019s gangrene associated with ertugliflozin. A 51-year-old male was admitted due to scrotal pain, urinary urgency, and subjective infectious symptoms. He was diagnosed with Fournier\u2019s gangrene, likely related to patient\u2019s home medication of ertugliflozin. Management and hospital course included antimicrobial and antifungal courses and was complicated by numerous surgical debridements by the urology team. After over 2 weeks, patient was discharged to rehabilitation facility. This report reiterates the importance of awareness of Fournier\u2019s gangrene as a potential adverse event of sodium-glucose cotransporter-2 inhibitors, including ertugliflozin.<\/jats:p>","DOI":"10.1177\/08971900251364050","type":"journal-article","created":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T07:23:03Z","timestamp":1753687383000},"page":"335-338","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":2,"title":["Fournier\u2019s Gangrene Associated With Ertugliflozin"],"prefix":"10.1177","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8150-0610","authenticated-orcid":false,"given":"Megan Kunka","family":"Fritz","sequence":"first","affiliation":[{"name":", University of Kentucky HealthCare"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2025,7,28]]},"reference":[{"issue":"1","key":"e_1_3_3_2_2","first-page":"158","article-title":"American diabetes association pharmacologic approaches to glycemic treatment: Standards of care in diabetes 2024","volume":"47","year":"2024","unstructured":"American diabetes association pharmacologic approaches to glycemic treatment: Standards of care in diabetes 2024. Diabetes Care. 2024;47(Suppl 1):158-178.","journal-title":"Diabetes Care"},{"key":"e_1_3_3_3_2","volume-title":"FDA Warns about Rare Occurrences of a Serious Infection of the Genital Area with SGLT2 Inhibitors for Diabetes","author":"US Food and Drug Administration (FDA)","year":"2018","unstructured":"US Food and Drug Administration (FDA). FDA Warns about Rare Occurrences of a Serious Infection of the Genital Area with SGLT2 Inhibitors for Diabetes. US Department of Health and Human Services. August 29, 2018. https:\/\/www.fda.gov\/drug\/drug-safety-and-availability (Accessed June 25, 2019)."},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1111\/dme.13508"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1111\/1753-0407.12896"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/3695101"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1981.154"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.asjsur.2012.04.006"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jemermed.2019.06.023"},{"issue":"10","key":"e_1_3_3_10_2","first-page":"e18948","article-title":"Fournier\u2019s gangrene diagnosis and treatment: a systematic review","volume":"13","author":"Lewis GD","year":"2021","unstructured":"Lewis GD, Majeed M, Olang CA, et al. Fournier\u2019s gangrene diagnosis and treatment: a systematic review. Cureus. 2021;13(10):e18948.","journal-title":"Cureus"}],"container-title":["Journal of Pharmacy Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/08971900251364050","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/08971900251364050","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/08971900251364050","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T03:56:52Z","timestamp":1782532612000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/08971900251364050"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,28]]},"references-count":9,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["10.1177\/08971900251364050"],"URL":"https:\/\/doi.org\/10.1177\/08971900251364050","relation":{},"ISSN":["0897-1900","1531-1937"],"issn-type":[{"value":"0897-1900","type":"print"},{"value":"1531-1937","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,28]]}}}